Reduced TP53 activity could impair DNA repair and stress responses, while F5 upregulation may contribute to hypercoagulation and peripheral inflammatory activation, potentially compromising the blood–brain barrier and exacerbating neuroinflammation. The gene discussed is TP53; the disease is thrombophilia.